These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 30335080)
1. [Non-motor disorders in patients with muscular dystonia]. Salouchina NI; Nodel MR; Tolmacheva VA Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):98-105. PubMed ID: 30335080 [TBL] [Abstract][Full Text] [Related]
2. Sleep in patients with primary dystonia: A systematic review on the state of research and perspectives. Hertenstein E; Tang NK; Bernstein CJ; Nissen C; Underwood MR; Sandhu HK Sleep Med Rev; 2016 Apr; 26():95-107. PubMed ID: 26164369 [TBL] [Abstract][Full Text] [Related]
10. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Kraft SP; Lang AE CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771 [TBL] [Abstract][Full Text] [Related]
11. Dystonic frowning without blepharospasm. Hirota N; Hirota M; Mezaki T Parkinsonism Relat Disord; 2008 Nov; 14(7):579-80. PubMed ID: 18316230 [TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life outcomes from botulinumtoxin treatment in blepharospasm. Weiss D; Hieber L; Sturm J; Börtlein A; Buchthal J; Dippon C; Arnold G; Wächter T Clin Neurol Neurosurg; 2018 Sep; 172():130-133. PubMed ID: 29990961 [TBL] [Abstract][Full Text] [Related]
13. Obsessive-compulsive symptoms in primary focal dystonia: a controlled study. Barahona-Corrêa B; Bugalho P; Guimarães J; Xavier M Mov Disord; 2011 Oct; 26(12):2274-8. PubMed ID: 21830232 [TBL] [Abstract][Full Text] [Related]
14. Cognitive Flexibility in Primary Dystonia. Lange F; Seer C; Dengler R; Dressler D; Kopp B J Int Neuropsychol Soc; 2016 Jul; 22(6):662-70. PubMed ID: 27333537 [TBL] [Abstract][Full Text] [Related]
15. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin]. Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208 [TBL] [Abstract][Full Text] [Related]
16. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin]. Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035 [TBL] [Abstract][Full Text] [Related]
17. Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes. Timmers ER; Smit M; Kuiper A; Bartels AL; van der Veen S; van der Stouwe AMM; Santens P; Bergmans B; Tijssen MAJ Parkinsonism Relat Disord; 2019 Dec; 69():85-90. PubMed ID: 31706131 [TBL] [Abstract][Full Text] [Related]
18. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762 [TBL] [Abstract][Full Text] [Related]
19. The Use of Botulinum Toxin for Treatment of the Dystonias. Berardelli A; Conte A Handb Exp Pharmacol; 2021; 263():107-126. PubMed ID: 31820178 [TBL] [Abstract][Full Text] [Related]
20. The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Stamelou M; Edwards MJ; Hallett M; Bhatia KP Brain; 2012 Jun; 135(Pt 6):1668-81. PubMed ID: 21933808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]